These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Primary sequence mapping of human apolipoprotein B-100 epitopes. Comparisons of trypsin accessibility and immunoreactivity and implication for apoB conformation. Chen PF, Marcel YL, Yang CY, Gotto AM, Milne RW, Sparrow JT, Chan L. Eur J Biochem; 1988 Jul 15; 175(1):111-8. PubMed ID: 2456922 [Abstract] [Full Text] [Related]
3. Monoclonal antibodies to human low density lipoprotein identify distinct areas on apolipoprotein B-100 relevant to the low density lipoprotein-receptor interaction. Fantappiè S, Corsini A, Sidoli A, Uboldi P, Granata A, Zanelli T, Rossi P, Marcovina S, Fumagalli R, Catapano AL. J Lipid Res; 1992 Aug 15; 33(8):1111-21. PubMed ID: 1279088 [Abstract] [Full Text] [Related]
4. Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products. Wang X, Bucala R, Milne R. Proc Natl Acad Sci U S A; 1998 Jun 23; 95(13):7643-7. PubMed ID: 9636203 [Abstract] [Full Text] [Related]
5. Regional specificities of monoclonal anti-human apolipoprotein B antibodies. Krul ES, Kleinman Y, Kinoshita M, Pfleger B, Oida K, Law A, Scott J, Pease R, Schonfeld G. J Lipid Res; 1988 Jul 23; 29(7):937-47. PubMed ID: 2457642 [Abstract] [Full Text] [Related]
6. Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. Pease RJ, Milne RW, Jessup WK, Law A, Provost P, Fruchart JC, Dean RT, Marcel YL, Scott J. J Biol Chem; 1990 Jan 05; 265(1):553-68. PubMed ID: 1688435 [Abstract] [Full Text] [Related]
8. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans. Goldberg IJ, Wagner WD, Pang L, Paka L, Curtiss LK, DeLozier JA, Shelness GS, Young CS, Pillarisetti S. J Biol Chem; 1998 Dec 25; 273(52):35355-61. PubMed ID: 9857078 [Abstract] [Full Text] [Related]
12. Epitope mapping analysis of apolipoprotein B-100 using a surface plasmon resonance-based biosensor. Laricchia Robbio L, Uboldi P, Marcovina S, Revoltella RP, Catapano AL. Biosens Bioelectron; 2001 Dec 15; 16(9-12):963-9. PubMed ID: 11679276 [Abstract] [Full Text] [Related]
13. Localization of the thyroxine binding sites in apolipoprotein B-100 of human low density lipoproteins. Benvenga S, Cahnmann HJ, Robbins J. Endocrinology; 1990 Nov 15; 127(5):2241-6. PubMed ID: 2226312 [Abstract] [Full Text] [Related]
14. Mapping of human apolipoprotein B antigenic determinants. Marcel YL, Innerarity TL, Spilman C, Mahley RW, Protter AA, Milne RW. Arteriosclerosis; 1987 Nov 15; 7(2):166-75. PubMed ID: 2437897 [Abstract] [Full Text] [Related]
15. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein. Keidar S, Brook GJ, Rosenblat M, Fuhrman B, Dankner G, Aviram M. Arterioscler Thromb; 1992 Apr 15; 12(4):484-93. PubMed ID: 1373074 [Abstract] [Full Text] [Related]
16. Rat monoclonal antibodies to human apolipoprotein B: advantages and applications. Fievet C, Durieux C, Milne R, Delaunay T, Agnani G, Bazin H, Marcel Y, Fruchart JC. J Lipid Res; 1989 Jul 15; 30(7):1015-24. PubMed ID: 2477482 [Abstract] [Full Text] [Related]